Differential regulation of airway smooth muscle cell migration by e-prostanoid receptor subtypes

Hiromichi Aso, Satoru Ito, Akemi Mori, Nobukazu Suganuma, Masataka Morioka, Norihiro Takahara, Masashi Kondo, Yoshinori Hasegawa

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Migration of airway smooth muscle (ASM) cells plays an important role in the pathophysiology of airway hyperresponsiveness and remodeling in asthma. It has been reported that prostaglandin (PG)E2 inhibits migration of ASM cells. Although PGE2 regulates cellular functions via binding to distinct prostanoid EP receptors, the role of EP receptor subtypes in mechanisms underlying cell migration has not been fully elucidated. We investigated the role of EP receptors in the inhibitory effects of PGE2 on the migration ofhuman ASM cells. Migration induced by platelet-derived growth factor (PDGF)-BB (10 ng/ml, 6 h) was assessed by a chemotaxis chamber assay. PDGF-BB-induced cell migration was inhibited by PGE2, the specific EP2 agonist ONO-AE1-259-01, the specific EP4 agonist ONO-AE1-329, and cAMP-mobilizing agents. The inhibition of cell migration by PGE2 was significantly reversed by a blockade of EP2 and EP4 receptors using antagonists or transfection with siRNAs. Moreover, PGE2, the EP2 agonist, and the EP4 agonist significantly increased phosphorylation of small heat shock protein 20, one of the protein substrates for protein kinaseA(PKA), with depolymerization of actin. In contrast, the EP3 agonist ONO-AE-248 significantly promoted baseline cell migration without affecting PDGF-BB-induced cell migration. In summary, activation of EP2 and EP4 receptors and subsequent activation of the cAMP/PKA pathway are the main mechanisms of inhibition of ASMcellmigration by PGE2. HSP20 phosphorylation by PKAis possibly involved in thismechanism.Conversely, EP3 is potent in promoting cell migration. EP receptor subtypes may be novel therapeutic targetmolecules in airway remodeling and asthma.

Original languageEnglish
Pages (from-to)322-329
Number of pages8
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume48
Issue number3
DOIs
Publication statusPublished - 01-03-2013

Fingerprint

Dinoprostone
Prostaglandins
Smooth Muscle Myocytes
Cell Movement
Muscle
Cells
Airway Remodeling
Phosphorylation
HSP20 Heat-Shock Proteins
Asthma
Chemical activation
Cell Migration Inhibition
Small Heat-Shock Proteins
Depolymerization
Proteins
Chemotaxis
Transfection
Actins
Assays
Substrates

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Aso, Hiromichi ; Ito, Satoru ; Mori, Akemi ; Suganuma, Nobukazu ; Morioka, Masataka ; Takahara, Norihiro ; Kondo, Masashi ; Hasegawa, Yoshinori. / Differential regulation of airway smooth muscle cell migration by e-prostanoid receptor subtypes. In: American Journal of Respiratory Cell and Molecular Biology. 2013 ; Vol. 48, No. 3. pp. 322-329.
@article{8a0942abea484041a082b2da55d1f921,
title = "Differential regulation of airway smooth muscle cell migration by e-prostanoid receptor subtypes",
abstract = "Migration of airway smooth muscle (ASM) cells plays an important role in the pathophysiology of airway hyperresponsiveness and remodeling in asthma. It has been reported that prostaglandin (PG)E2 inhibits migration of ASM cells. Although PGE2 regulates cellular functions via binding to distinct prostanoid EP receptors, the role of EP receptor subtypes in mechanisms underlying cell migration has not been fully elucidated. We investigated the role of EP receptors in the inhibitory effects of PGE2 on the migration ofhuman ASM cells. Migration induced by platelet-derived growth factor (PDGF)-BB (10 ng/ml, 6 h) was assessed by a chemotaxis chamber assay. PDGF-BB-induced cell migration was inhibited by PGE2, the specific EP2 agonist ONO-AE1-259-01, the specific EP4 agonist ONO-AE1-329, and cAMP-mobilizing agents. The inhibition of cell migration by PGE2 was significantly reversed by a blockade of EP2 and EP4 receptors using antagonists or transfection with siRNAs. Moreover, PGE2, the EP2 agonist, and the EP4 agonist significantly increased phosphorylation of small heat shock protein 20, one of the protein substrates for protein kinaseA(PKA), with depolymerization of actin. In contrast, the EP3 agonist ONO-AE-248 significantly promoted baseline cell migration without affecting PDGF-BB-induced cell migration. In summary, activation of EP2 and EP4 receptors and subsequent activation of the cAMP/PKA pathway are the main mechanisms of inhibition of ASMcellmigration by PGE2. HSP20 phosphorylation by PKAis possibly involved in thismechanism.Conversely, EP3 is potent in promoting cell migration. EP receptor subtypes may be novel therapeutic targetmolecules in airway remodeling and asthma.",
author = "Hiromichi Aso and Satoru Ito and Akemi Mori and Nobukazu Suganuma and Masataka Morioka and Norihiro Takahara and Masashi Kondo and Yoshinori Hasegawa",
year = "2013",
month = "3",
day = "1",
doi = "10.1165/rcmb.2012-0158OC",
language = "English",
volume = "48",
pages = "322--329",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "3",

}

Differential regulation of airway smooth muscle cell migration by e-prostanoid receptor subtypes. / Aso, Hiromichi; Ito, Satoru; Mori, Akemi; Suganuma, Nobukazu; Morioka, Masataka; Takahara, Norihiro; Kondo, Masashi; Hasegawa, Yoshinori.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 48, No. 3, 01.03.2013, p. 322-329.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential regulation of airway smooth muscle cell migration by e-prostanoid receptor subtypes

AU - Aso, Hiromichi

AU - Ito, Satoru

AU - Mori, Akemi

AU - Suganuma, Nobukazu

AU - Morioka, Masataka

AU - Takahara, Norihiro

AU - Kondo, Masashi

AU - Hasegawa, Yoshinori

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Migration of airway smooth muscle (ASM) cells plays an important role in the pathophysiology of airway hyperresponsiveness and remodeling in asthma. It has been reported that prostaglandin (PG)E2 inhibits migration of ASM cells. Although PGE2 regulates cellular functions via binding to distinct prostanoid EP receptors, the role of EP receptor subtypes in mechanisms underlying cell migration has not been fully elucidated. We investigated the role of EP receptors in the inhibitory effects of PGE2 on the migration ofhuman ASM cells. Migration induced by platelet-derived growth factor (PDGF)-BB (10 ng/ml, 6 h) was assessed by a chemotaxis chamber assay. PDGF-BB-induced cell migration was inhibited by PGE2, the specific EP2 agonist ONO-AE1-259-01, the specific EP4 agonist ONO-AE1-329, and cAMP-mobilizing agents. The inhibition of cell migration by PGE2 was significantly reversed by a blockade of EP2 and EP4 receptors using antagonists or transfection with siRNAs. Moreover, PGE2, the EP2 agonist, and the EP4 agonist significantly increased phosphorylation of small heat shock protein 20, one of the protein substrates for protein kinaseA(PKA), with depolymerization of actin. In contrast, the EP3 agonist ONO-AE-248 significantly promoted baseline cell migration without affecting PDGF-BB-induced cell migration. In summary, activation of EP2 and EP4 receptors and subsequent activation of the cAMP/PKA pathway are the main mechanisms of inhibition of ASMcellmigration by PGE2. HSP20 phosphorylation by PKAis possibly involved in thismechanism.Conversely, EP3 is potent in promoting cell migration. EP receptor subtypes may be novel therapeutic targetmolecules in airway remodeling and asthma.

AB - Migration of airway smooth muscle (ASM) cells plays an important role in the pathophysiology of airway hyperresponsiveness and remodeling in asthma. It has been reported that prostaglandin (PG)E2 inhibits migration of ASM cells. Although PGE2 regulates cellular functions via binding to distinct prostanoid EP receptors, the role of EP receptor subtypes in mechanisms underlying cell migration has not been fully elucidated. We investigated the role of EP receptors in the inhibitory effects of PGE2 on the migration ofhuman ASM cells. Migration induced by platelet-derived growth factor (PDGF)-BB (10 ng/ml, 6 h) was assessed by a chemotaxis chamber assay. PDGF-BB-induced cell migration was inhibited by PGE2, the specific EP2 agonist ONO-AE1-259-01, the specific EP4 agonist ONO-AE1-329, and cAMP-mobilizing agents. The inhibition of cell migration by PGE2 was significantly reversed by a blockade of EP2 and EP4 receptors using antagonists or transfection with siRNAs. Moreover, PGE2, the EP2 agonist, and the EP4 agonist significantly increased phosphorylation of small heat shock protein 20, one of the protein substrates for protein kinaseA(PKA), with depolymerization of actin. In contrast, the EP3 agonist ONO-AE-248 significantly promoted baseline cell migration without affecting PDGF-BB-induced cell migration. In summary, activation of EP2 and EP4 receptors and subsequent activation of the cAMP/PKA pathway are the main mechanisms of inhibition of ASMcellmigration by PGE2. HSP20 phosphorylation by PKAis possibly involved in thismechanism.Conversely, EP3 is potent in promoting cell migration. EP receptor subtypes may be novel therapeutic targetmolecules in airway remodeling and asthma.

UR - http://www.scopus.com/inward/record.url?scp=84874831860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874831860&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2012-0158OC

DO - 10.1165/rcmb.2012-0158OC

M3 - Article

C2 - 23221043

AN - SCOPUS:84874831860

VL - 48

SP - 322

EP - 329

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 3

ER -